• 1
    Licht MR, Klein EA. Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate. Urology 1994; 44(5): 7004.
  • 2
    Koch MO, Smith JA Jr. Clinical outcomes associated with the implementation of a cost-efficient programme for radical retropubic prostatectomy. Br J Urol 1995; 76(1): 2833.
  • 3
    Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years [see comments]. J Urol 1994; 152( 5 Pt 2): 18316.
  • 4
    Frazier HA, Robertson JE, Paulson DF. Radical prostatectomy: the pros and cons of the perineal versus retropubic approach. J Urol 1992; 147( 3 Pt 2): 88890.
  • 5
    Weiss JP, Schlecker BA, Wein AJ, Hanno PM. Preservation of periprostatic autonomic nerves during total perineal prostatectomy by intrafascial dissection. Urology 1985; 26(2): 1603.
  • 6
    Theodorescu D, Lippert MC, Broder SR, Boyd JC. Early prostate-specific antigen failure following radical perineal versus retropubic prostatectomy: the importance of seminal vesicle excision. Urology 1998; 51(2): 27782.
  • 7
    Bishoff JT, Motley G, Optenberg SA, Stein CR, Moon KA, Browning SM, et al. Incidence of fecal and urinary incontinence following radical perineal and retropubic prostatectomy in a national population. J Urol 1998; 160(2): 4548.
  • 8
    Sobin LH, Wittekind C. TNM classification of malignant tumors. 5th edition. New York: John Wiley & Sons, 1997.
  • 9
    Prause G, Ratzenhofer-Comenda B, Pierer G, Smolle-Juttner F, Glanzer H, Smolle J. Can ASA grade or Goldman's cardiac risk index predict peri-operative mortality? A study of 16,227 patients. Anaesthesia 1997;52(3): 2036.
  • 10
    See WA, Fuller JR, Toner ML. An outcome study of patient-controlled morphine analgesia, with or without ketorolac, following radical retropubic prostatectomy [see comments]. J Urol 1995; 154(4): 142932.
  • 11
    Weisberg S. Applied linear regression. New York: John Wiley & Sons, 1985.
  • 12
    Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
  • 13
    Lawless JF. Statistical models and methods for lifetime data. New York: John Wiley & Sons, 1982.
  • 14
    McCullage P, Melder J. Generalized linear models. London: Chapman & Hall, 1983.
  • 15
    Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998; 48(1): 629.
  • 16
    Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol 1997; 15(3): 101321.
  • 17
    Blasko JC, Ragde H, Luse RW, Sylvester JE, Cavanagh W, Grimm PD. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am 1996; 23(4): 63350.
  • 18
    Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83(8): 167984.
  • 19
    Polascik TJ, Pound CR, DeWeese TL, Walsh PC. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. Urology 1998; 51(6): 8849; discussion 889–90.
  • 20
    D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280(11): 96974.
  • 21
    Harris MJ, Thompson IM Jr. The anatomic radical perineal prostatectomy: a contemporary and anatomic approach. Urology 1996; 48(5): 7628.
  • 22
    Doublet JD, Lagrange L, Ciofu C, Thibault P, Gattegno B. Radical prostatectomy: comparison of the perineal and retropubic route (40 patients). Preliminary results [in French]. Prog Urol 1994;4(1): 339.
  • 23
    Weldon VE, Tavel FR, Neuwirth H. Continence, potency and morbidity after radical perineal prostatectomy [see comments]. J Urol 1997; 158(4): 14705.
  • 24
    Gray M, Petroni GR, Theodorescu D. Urinary function after radical prostatectomy: a comparison of the retropubic and perineal approaches. Urology 1999; 53(5): 88190.
  • 25
    Fowler JE Jr. Radical prostatectomy for stage A2 and B prostatic carcinoma. Operative experience. Urology 1985;26(1): 13.
  • 26
    Litwin MS, Kahn KL, Reccius N. Why do sicker patients cost more? A charge-based analysis of patients undergoing prostatectomy. J Urol 1993;149(1): 848.
  • 27
    Koch MO. Cost-efficient radical prostatectomy. Semin Urol Oncol 1995; 13(3): 197203.
  • 28
    Palmer JS, Worwag EM, Conrad WG, Blitz BF, Chodak GW. SAme day surgery for radical retropubic prostatectomy: is it an attainable goal? [see comments]. Urology 1996;47(1): 238.
  • 29
    Klein EA, Grass JA, Calabrese DA, Kay RA, Sargeant W, O'Hara JF. Maintaining quality of care and patient satisfaction with radical prostatectomy in the era of cost containment. Urology 1996; 48(2): 26976.
  • 30
    Stevens RA, Mikat-Stevens M, Flanigan R, Waters WB, Furry P, Sheikh T, et al. Does the choice of anesthetic technique affect the recovery of bowel function after radical prostatectomy? Urology 1998; 52(2): 2138.
  • 31
    Gottschalk A, Smith DS, Jobes DR, Kennedy SK, Lally SE, Noble VE, et al. Preemptive epidural analgesia and recovery from radical prostatectomy: a randomized controlled trial see comments]. JAMA 1998; 279(14): 107682.